Homeostatic mechanisms operate to stabilize synaptic function; however, we know little about how they are regulated. Exploiting Drosophila genetics, we have uncovered a critical role for the target of rapamycin (TOR) in the regulation of synaptic homeostasis at the Drosophila larval neuromuscular junction. Loss of postsynaptic TOR disrupts a retrograde compensatory enhancement in neurotransmitter release that is normally triggered by a reduction in postsynaptic glutamate receptor activity. Moreover, postsynaptic overexpression of TOR or a phosphomimetic form of S6 ribosomal protein kinase, a common target of TOR, can trigger a strong retrograde increase in neurotransmitter release. Interestingly, heterozygosity for eIF4E, a critical component of the cap-binding protein complex, blocks the retrograde signal in all these cases. Our findings suggest that cap-dependent translation under the control of TOR plays a critical role in establishing the activity dependent homeostatic response at the NMJ.
INTRODUCTION
At both vertebrate and invertebrate synapses, alterations in synaptic activity trigger homeostatic responses that modulate synaptic strength; it appears that these homeostatic responses manifest as changes in postsynaptic receptor expression as well as retrograde regulation of transmitter release (Branco et al., 2008; Cai et al., 2008; Davis, 2006; Goold and Nicoll, 2010; Jakawich et al., 2010; Petersen et al., 1997; Sandrock et al., 1997; Stellwagen and Malenka, 2006; Sutton and Schuman, 2006; Turrigiano and Nelson, 2004; Turrigiano et al., 1998) . Postsynaptic translation plays an important role in local changes in postsynaptic receptor expression (Bidinosti et al., 2010; Costa-Mattioli et al., 2009; Menon et al., 2004; Sigrist et al., 2000; Sutton et al., 2007) ; however, we know little about whether translational mechanisms also participate in the retrograde control of neurotransmitter release. At the Drosophila larval neuromuscular junction (NMJ), loss or inhibition of glutamate receptor subunit IIA (GluRIIA) triggers a robust retrograde increase in neurotransmitter release to compensate for the reduction in postsynaptic receptor function (Frank et al., 2006; Petersen et al., 1997) . We investigated whether this retrograde signaling during larval development was dependent on translational regulation, as are many other forms of synaptic plasticity (Costa-Mattioli et al., 2009) .
A number of regulatory mechanisms modulate translation at the level of translation initiation (Sonenberg and Hinnebusch, 2009) . Two critical steps in translation initiation are the binding of the cap-binding protein complex with the 5 0 end cap structure of mRNAs (m7GpppN), which is responsible for unwinding the secondary structure of mRNAs 5 0 UTR (untranslated region), and the formation of the ternary complex, which mediates the binding of Met-tRNA i Met to the 40S ribosomal subunit (Sonenberg and Hinnebusch, 2009 ). The eukaryotic initiation factors eIF4E and eIF2a are important components of the cap-binding protein complex and the ternary complex, respectively. Both of these initiation factors are tightly regulated through a host of molecular interactions in cells (Sonenberg and Hinnebusch, 2009 ).
An important level of regulation of cap-dependent translation is mediated by the target of rapamycin (TOR). This evolutionary conserved kinase plays a central role in linking many cellular and environmental cues to cell metabolism, growth, and proliferation in all eukaryotes (Ma and Blenis, 2009) . Accumulating evidence suggests that TOR activity can also specifically influence synaptic growth, function, and plasticity in postmitotic neurons and during disease (Buckmaster et al., 2009; Ehninger et al., 2008; Hoeffer and Klann, 2010; Sharma et al., 2010; Swiech et al., 2008; Tang et al., 2002) . TOR activity promotes cap-dependent translation primarily through phosphorylation of 4E-BPs (eIF4E binding proteins) and p70 S6Ks (S6 ribosomal protein kinases) (Ma and Blenis, 2009 ). Mammalian genomes encode three 4E-BP and two S6k genes, while Drosophila possess only one of each. Phosphorylation of 4E-BP suppresses its ability to bind to and inhibit eIF4E, thus enhancing the interaction of the cap-binding protein complex with the mRNA 5 0 cap (Sonenberg and Hinnebusch, 2009 ). In parallel, TOR phosphorylation of S6K activates its ability to phosphorylate a number of downstream targets. S6K is best known for phosphorylation of ribosomal protein S6 and promoting the translation of a group of mRNAs that have an oligopyrimidine tract at their transcriptional start (5 0 TOP mRNAs), which encode important components of the translational machinery (Jefferies et al., 1997; Ma and Blenis, 2009 ). In addition, S6K activity promotes the helicase function of the cap-binding complex by enhancing the action of initiation factor eIF4A. S6K phosphorylates and inhibits PDCD4 (programmed cell death protein 4), a negative regulator of eIF4A, and directly phosphorylates eIF4B, a positive regulator of eIF4A (Dorrello et al., 2006; Gingras et al., 2001; Holz et al., 2005; Shahbazian et al., 2010) .
We took advantage of the genetic tools in Drosophila to examine how manipulating some of the molecules central to translational regulation may affect the ability of NMJ synapses to undergo retrograde homeostatic compensation. Our multidisciplinary analysis indicates that a postsynaptic pathway that regulates the availability of eIF4E and the efficiency of capdependent translation, under the control of TOR, is responsible for the regulation of the retrograde signaling that controls synaptic homeostasis.
RESULTS
eIF4E, but Not eIF2a, Is Critical for Homeostatic Compensation in GluRIIA Mutants When compared to wild-type larvae, GluRIIA mutant larvae have reduced mEJCs (miniature excitatory junctional currents) but normal EJCs (evoked excitatory junctional currents), indicating a greatly enhanced synaptic strength or quantal content (QC, or the number of vesicles released per presynaptic action potential) (Petersen et al., 1997 ; Figures 1A-1D) . We tested the role of translational regulation in this homeostatic response by manipulating two key players in translation initiation, the eukaryotic initiation factors eIF4E and eIF2a. Genetic removal of one copy of eIF4E greatly suppressed the ability of the NMJ to induce a retrograde enhancement in neurotransmitter release in GluRIIA mutants, while removal of one copy of eIF2a had no effect (Figures 1A-1D ; also see Table S1 for all statistics and Table  S2 for a description of the translation mutants used in this study [available online]). The lack of any effect on retrograde compensation in eIF2a G0272 heterozygous larvae could be due to the hypomorphic nature of the mutation (Figures S1A and S1B and  Table S2 ); in other words, one could argue that we have not decreased the level of eIF2a enough. To address this issue, we generated a genetic combination in which we could record the electrophysiological consequences of loss of GluRIIA in hemizygous eIF2a G0272 males. The hemizygous male eIF2a G0272 larvae had significantly reduced levels of eIF2a transcript and protein and showed a significant delay in larval development as well as decreased muscle size ( Figure S1 and Table S2 ). Nevertheless, the average number of NMJ boutons in these larvae was not significantly different from that in control larvae and retrograde compensation was still intact in eIF2a G0272 ; GluRIIA double mutants ( Figures 1B-1D and S1C-S1E). These results indicate that the sustained homeostatic regulation of synaptic strength in GluRIIA mutant larvae is particularly sensitive to the availability/function of the cap-binding complex rather than translation initiation in general.
TOR Is Required for the Homeostatic Response in GluRIIA Mutants
A large body of evidence in both vertebrates and invertebrates has implicated TOR-dependent translational regulation in synaptic plasticity and behavioral paradigms (Banko et al., 2006; Costa-Mattioli et al., 2009; Ehninger et al., 2008; Gobert et 20, 26, 16, 16, 15 . Synaptic homeostasis in GluRIIA mutants is dominantly suppressed by heterozygosity for eIF4E but not eIF2a. Error bars represent SEM. **p < 0.01, ***p < 0.001. See also Figure S1 and Tables S1 and S2. et al., 2002) ; however, we know little about the mode of action of TOR and whether TOR plays a role in the regulation of synaptic homeostasis.
Neuron
Based on the critical requirement for eIF4E in the retrograde regulation of synaptic transmission, we predicted that TOR, a major cellular regulator of cap-dependent translation, would likely function in a similar fashion. Indeed, we found that removal of one copy of the Tor gene profoundly suppressed the retrograde compensation in GluRIIA mutants (Figures 2A and 2B) . Because of the wide spread role of eIF4E and TOR in translational regulation, we wished to rule out the possibility that heterozygosity for these genes had a significant effect on the overall development of larval NMJs or baseline neurotransmission. Our analysis revealed no significant abnormalities in the number of synaptic boutons or the size of the muscles when we compared heterozygous larvae for Tor or eIF4E with control larvae (Figures 2C-2F) . Similarly, the baseline electrophysiological properties in the heterozygous mutants were indistinguishable from those in control larvae ( Figure 2G ). Next, to rule out a defect in the number of presynaptic release sites in the heterozygous mutants, we examined the synaptic boutons in wild-type, (Kittel et al., 2006) . We found no differences in the number of or the density of active zones based on Brp antibody staining ( Figures 2H-2Q ). Finally, to test for effects on postsynaptic glutamate receptors, we quantified the immunofluorescence staining intensity of Glutamate receptor IIC (GluRIIC) staining in Tor or eIF4E heterozygotes, again finding no differences relative to wild-type ( Figure 2R ).
To understand the role of TOR in more detail, we took advantage of hypomorphic Tor mutants (Tor E161K /Tor DP ) that can live to complete larval stages (Zhang et al., 2006) . These Tor mutant larvae showed a significant reduction in levels of phosphorylated 4E-BP and S6K, indicating that TOR activity in this allelic combination is reduced ( Figure S2A ). We examined the morphological properties of the NMJs and surprisingly found no significant difference in the number of synaptic boutons in Tor E161K /Tor DP mutants compared to that in control larvae ( Figures S2B-S2D) ; however, muscles were on average smaller than control counterparts, reminiscent of what we observed in eIF2a G0272 hemizygous males and consistent with the role of TOR in promoting growth ( Figure S2D ). Muscle size was restored in Tor E161K /Tor DP mutants by overexpressing a TOR transgene in all muscles using MHC-Gal4 ( Figure S2D ). Finally, we assessed the number of presynaptic active zones and accumulation of several pre-and post-synaptic markers and found no significant differences between Tor E161K /Tor DP mutants and control larvae . These results suggest that considerably reduced levels of TOR in these hypomorphic mutants can still meet the requirements for normal growth of presynaptic structures during larval growth, while mere heterozygosity for Tor, which has no effect on muscle and NMJ growth or baseline neurotransmission, is sufficient to severely block the retrograde increase of neurotransmitter release in GluRIIA mutants.
GluRIIA Levels Are Reduced in Both eIF2a and Tor Mutants Our electrophysiological analysis of Tor mutant larvae showed a mild but statistically significant reduction in the average amplitude of mEJCs (Figures 3A and 3B) . Postsynaptic receptors at the NMJ are non-NMDA type ionotropic glutamate receptors. Genetic and electrophysiological findings have identified five GluR subunits: IIA, IIB, IIC (or III), IID, and IIE, of which IIC, IID, and IIE are essential, while IIA or IIB can replace each other to form a functional tetrameric receptor with the other three subunits (Marrus et al., 2004; Petersen et al., 1997; Qin et al., 2005) . Loss of GluRIIA leads to a strong decrease in the singlechannel mean open time, giving rise to smaller mEJCs and mEJPs (DiAntonio et al., 1999) . Consistent with the reduction in mEJC amplitude in Tor mutants, we found a mild but statistically significant reduction in the immunofluorescence associated with GluRIIA at postsynaptic sites in Tor E161K /Tor DP larvae ( Figures   3C-3E ), supporting a link between GluRIIA expression and local synaptic translation as previously shown (Sigrist et al., 2000) . The EJCs recorded from Tor mutants were also proportionally smaller than those in wild-type larvae resulting in statistically unchanged values for QC measurements ( Figures 3A and 3B ). Since hemizygous male eIF2a G0272 mutants, described above, showed a similar reduction in postsynaptic muscle growth as Tor mutants, these results prompted us to test ) muscle 4, segment A3 NMJs stained with monoclonal anti-glutamate receptor IIA (GluRIIA, green). Scale bar, 10 mm. (E) Quantification of the GluRIIA immunofluorescence intensity for the indicated genotypes. n = 29 and 30. Two-tailed student's t test was applied for the comparison. (F) Wild-type (w 1 ) and (G) eIF2a mutant (eIF2a GO272/Y ) muscle 4 NMJs stained with anti-GluRIIA (green). Scale bar, 10 mm.
(H) Quantification of the GluRIIA immunofluorescence intensity in the indicated genotypes. n = 25 for both. Two-tailed student's t test was applied for the comparison.
(I) EJCs and mEJCs in wild-type (w
1118
) and eIF2a mutants. Scale bars, 10 nA/40 ms for EJCs and 2 nA/400 ms for mEJCs. (J) Quantification of mEJC, EJC, and QC for the indicated genotypes. n = 20 and 35. Two-tailed student's t test was applied for the comparison. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S2 . All error bars represent SEM.
whether eIF2a G0272 mutants also display a reduction in GluRIIA levels. Indeed, we found that eIF2a mutation led to a much larger reduction in GluRIIA than Tor mutation did ( Figures 3F-3H ). Consistently, eIF2a G0272 mutant larvae also showed a larger reduction in mEJCs (Figures 3I and 3J) . However, in contrast to Tor E161K /Tor DP mutant larvae, these larvae had normal EJCs, reflecting a strong increase in QC (Figures 3I and 3J) . This suggested that the reduction in mEJCs in eIF2a mutants had triggered a retrograde compensation leading to increased neurotransmitter release, again demonstrating that the homeostatic response in eIF2a mutants was intact. These results further demonstrate that while a significant reduction in translation in eIF2a G0272 and Tor E161K /Tor DP mutant larvae leads to qualitatively similar changes in muscle growth and GluRIIA levels, it has vastly different effects on retrograde signaling and neurotransmitter release.
TOR Acts in a Retrograde Manner to Regulate Synaptic Homeostasis
To address the tissue requirement of TOR, we took advantage of the UAS-Gal4 tissue specific expression system (Brand and Perrimon, 1993) and found that postsynaptic rather than presynaptic TOR activity is required for the homeostatic response. Transgenic overexpression of TOR in all muscles restored QC in GluRIIA
; TOR À/À double mutants, while neuronal expression of the same transgene had no effect ( Figures 4A and 4B ).
Similarly, transgenic overexpression of a TOR-RNAi transgene in muscles but not in motor neurons was capable of suppressing the homeostatic compensation in GluRIIA mutants (Figures 4C, 4D, and S3A) . These results provide the first genetic evidence indicating that TOR is involved in the regulation of retrograde signaling across the synapse, which is essential for the ability of the NMJ to undergo functional homeostasis. Next, we explored the temporal requirement for TOR activity, and asked whether TOR is required throughout larval development for the homeostatic response in GluRIIA mutants. For this we took advantage of the specific inhibitor of TOR, rapamycin (Loewith et al., 2002) and raised larvae on plates supplemented with 1 mM rapamycin. Raising larvae on rapamycin supplemented food during the last 3 days of larval life was sufficient to severely hamper the ability of GluRIIA mutant larvae to undergo homeostatic compensation ( Figure 4E ). The same manipulation had no effect on baseline electrophysiological properties of heterozygous larvae growing on the same plate (data not shown). We then planned additional experiments to test the effect of rapamycin ingestion within several hours. For these experiments we raised GluRIIA mutant larvae normally and transferred the genotypically verified larvae either to a control plate or a plate supplemented with 3 mM rapamycin. We found that GluRIIA mutants, after growing for 6 hr on rapamycin plates, were not different from those grown on control plates ( Figure 4E ). But after 12 hr of ingesting rapamycin containing food, we measured a strong reduction in the homeostatic response of the larvae ( Figure 4E ). Although it is difficult to estimate accurately how fast rapamycin takes effect in larvae, these results support the idea that TOR activity has to be sustained during larval development for the ability of the NMJ to undergo homeostatic compensation.
S6K and 4E-BP Influence Retrograde Signaling at the NMJ Cap-dependent translation is critically dependent on the availability of eIF4E. TOR ensures that eIF4E is available for interacting with the cap-binding protein complex by phosphorylating and thereby disrupting the ability of 4E-BP to inhibit eIF4E (Gingras et al., 2001; Sonenberg and Hinnebusch, 2009) . At the same time TOR phosphorylates S6K. Among other actions, S6K directly phosphorylates eIF4B and thereby promotes the helicase function of eIF4A, enhancing cap-dependent translation (Holz et al., 2005; Ma and Blenis, 2009; Shahbazian et al., 2010) . Our model, therefore, predicts that both S6K and 4E-BP would play a role in the regulation of synaptic homeostasis at the NMJ. We tested this possibility first by asking whether increasing the ability of 4E-BP to sequester eIF4E would block retrograde homeostatic signaling in GluRIIA mutants. Indeed, we found that muscle overexpression of a TOR-independent form of 4E-BP (4E-BP AA ) profoundly suppressed the increase in synaptic strength in GluRIIA mutants ( Figures 5A and 5B) . The same level of overexpression of 4E-BP AA , however, did not significantly affect the baseline transmission in otherwise wild-type larvae, suggesting that the suppression effect observed in GluRIIA mutants was not due to a general defect in synaptic transmission ( Figure 5B ). Then, we tested the role of S6K by conducting genetic interaction experiments between S6k and GluRIIA mutants. Our electrophysiological analysis showed that S6K is essential for the ability ; 24B-Gal4/+) and larvae heterozygous for S6k (+/S6k l-1 ). n = 14, 15, 9, 16, 9.
(C) Western blot analysis shows that phospho-S6K levels are increased in muscle from GluRIIA mutants relative to heterozygous controls. (D) Quantification of phosphorylated S6K, normalized to Actin, in GluRIIA mutants compared to heterozygous controls. n = 13. (E) Western blot analysis shows that the increase in phospho-S6K levels in GluRIIA mutants can be prevented by removal of one copy of Tor. Actin serves as a loading control.
(F) Quantification of phosphorylated S6K, normalized to Actin, in the genotypes shown in (F). n = 3. (G) Western blot analysis shows that levels of phospho-S6K are unaffected in larvae lacking one copy of Tor.
(H) Quantification of phosphorylated S6K, normalized to Actin, in Tor heterozygotes compared to wild-type larvae. n = 3. All error bars represent SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S4 .
of GluRIIA mutants to undergo homeostatic compensation: the increase in QC in GluRIIA mutant larvae was severely hampered when only one copy of S6k was genetically removed (Figures 5A and 5B) . This is as we found no statistical difference in baseline electrophysiology between wild-type larvae and larvae heterozygous for S6k ( Figure 5B) ; similarly, we found no differences in the number or density of presynaptic active zones or any change in the postsynaptic accumulation of GluRs in the two groups ( Figures S4A-S4C) . These results highlight S6K as an important player in the retrograde compensation of synaptic function at the NMJ. This is consistent with behavioral and synaptic plasticity defects observed in S6K1 and S6K2 mutant mice (Antion et al., 2008) . In addition to their role in homeostatic plasticity described above, S6k mutant larvae do show synaptic defects as recently reported (Cheng et al., 2011) ; our results are largely consistent with theirs ( Figures S4A-S4E) , showing a presynaptic defect in the number of active zones and a reduction in quantal content. However, our genetic interaction experiments between S6k and GluRIIA mutants used only heterozygous S6k combinations, which as described above are indistinguishable from wild-type larvae for the number of synaptic boutons, presynaptic release sites, postsynaptic densities or baseline electrophysiology ( Figures S4A-S4E ). To extend our results further, we explored the possibility that TOR activity might in fact be upregulated in GluRIIA mutants. For this, we set out to evaluate the level of phosphorylation of S6K using immunohistochemistry in wild-type and GluRIIA mutant larvae. Unfortunately, this approach did not produce a reliable and reproducible signal using available antibodies against the phosphorylated form of S6K (p-S6K) (data not shown). The inability of these antibodies to detect p-S6K in immunofluorescence experiments has also recently been reported by others (Lindquist et al., 2011) .
On the other hand, we were able to clearly detect a postsynaptic accumulation of eIF4E at the NMJ using an eIF4E GFP protein trap line. In these flies a GFP cassette has been inserted in frame into the eIF4E gene giving rise to a GFP::eIF4E protein product transcribed from the endogenous locus of eIF4E, closely reporting the endogenous expression of eIF4E (Quiñ ones-Coello et al., 2007) . In both wild-type and GluRIIA mutant larvae we found a clear accumulation of GFP associated with postsynaptic densities ( Figures S4H-S4T) ; although we observed a consistent trend for increase in the synaptic accumulation of eIF4E in GluRIIA mutant larvae, there was no statistical significance in the level of fluorescence between wild-type and mutant larvae.
For evaluating the level of phospho-S6K further, we turned to Western blot analysis from muscle extracts. We found a consistent increase in the amount of S6K phosphorylation relative to actin ( Figures 5C and 5D ) or relative to total S6K (Figures S4F and S4G) in homozygous GluRIIA mutants, when compared to heterozygous controls. Many postsynaptic translational mechanisms have been shown to operate locally at the synapse (Sutton et al., 2007) ; therefore, our results may be an underestimation of the relevant synaptic changes in S6K phosphorylation. Nevertheless, these findings suggest that indeed, TOR activity most likely is upregulated in GluRIIA mutants. To further test whether this increase in S6K phosphorylation depends on normal activity of TOR, we combined homozygous GluRIIA mutants with heterozygous Tor +/À mutants. Heterozygosity for Tor was sufficient to reduce the increase in S6K phosphorylation in GluRIIA mutants and restore wild-type levels ( Figures 5E and 5F ). Interestingly, we found no difference in levels of S6K phosphorylation between wild-type larva and Tor +/À heterozygous larvae ( Figures 5G and   5H ). These results together suggest that the induction of the retrograde signal is dependent on elevated levels of TOR/S6K activity.
Postsynaptic TOR Can Induce a Retrograde Increase in Synaptic Strength
Our results, described above, raised the intriguing possibility that TOR activation may be sufficient to induce a retrograde enhancement in neurotransmission at the NMJ. We turned to the UAS-Gal4 expression system to explore this possibility. Indeed, overexpression of a wild-type TOR transgene in postsynaptic muscles using either G14-Gal4 ( Figures 6A and 6B ) or MHC-Gal4 caused a significant increase in EJCs without affecting the average amplitude of mEJCs, reflecting a substantial increase in QC (55.28 ± 4.7 for MHC-Gal4 x UAS-TOR compared to 31.54 ± 1.7 for control; n = 12 and 20, respectively, p < 0.001 using Student's t test). To investigate whether a pre-or postsynaptic mechanism underlies this increase in QC, we analyzed mEJCs in more detail, but found no significant differences between mEJC amplitude distributions in control larvae and larvae overexpressing TOR ( Figure S5H ). Similarly, we found no change in the number of synaptic boutons ( Figures S5A-S5C ), number of presynaptic release sites ( Figures 6F-6O ), or in the expression level of glutamate receptor subunits GluRIIA or GluRIIC in response to TOR overexpression ( Figures S5D-S5G ). The lack of a change in the average amplitude of mEJCs ( Figure S5H ) is consistent with the lack of a change in immunofluoresence associated with GluRIIA and GluRIIC, together suggesting that the increase in QC is not likely due to an upregulation of postsynaptic receptors. To verify that indeed overexpression of TOR in muscles had caused a retrograde increase in presynaptic release probability we used a direct approach based on failure analysis. Failure analysis revealed a significant enhancement in release probability in larvae overexpressing TOR in muscles ( Figure 6C ), indicating that a presynaptic mechanism underlies the increase in QC. In addition, we found that the increase in QC due to TOR overexpression was critically dependent on Brp. We have previously demonstrated that removal of one copy of the brp gene does not affect baseline electrophysiological properties (Tsurudome et al., 2010) , but it does suppresses the ability of GluRIIA mutants to undergo retrograde compensation (Figure S5I) . Similarly, heterozygosity for brp profoundly inhibited the ability of postsynaptic TOR to induce an increase in QC, providing further evidence that the enhancement in QC in response to postsynaptic TOR overexpression relies on a presynaptic mechanism. These results together provide strong evidence that increased TOR activity can induce a retrograde increase in neurotransmitter release. Consistent with our model, the increase in QC due to TOR overexpression was also critically dependent on eIF4E and S6K, as heterozygosity for eIF4E or S6k greatly reduced the ability of TOR to induce a retrograde increase in QC ( Figures 6A and 6B) . These results indicate that TOR's influence on translation initiation most likely underlies its role as a retrograde regulator of synaptic homeostasis at the NMJ.
The strong sensitivity of the TOR-induced retrograde increase in QC to S6K prompted us to test whether muscle overexpression of a constitutively active S6K (S6K STDE ) transgene could mimic the action of TOR (Barcelo and Stewart, 2002) . As our results would predict, overexpression of S6K STDE in muscles led to a similar increase in average EJC amplitude and QC without affecting quantal size, consistent with the idea that TOR exerts its action largely through S6K to induce a retrograde increase in QC ( Figure 6D ). We also verified that postsynaptic overexpression of S6K STDE did not lead to any structural changes ( Figures 6F-6O ) or changes in mEJC distribution (Figure S5H) and that it indeed enhanced the probability of release presynaptically using failure analysis ( Figure 6E ). Finally, as our model would predict, we found that heterozygosity for eIF4E completely suppressed the QC increase due to overexpression of S6K STDE , suggesting that the aspect of S6K's function that contributes to the induction of retrograde signaling is critically dependent on the availability/function of the cap-binding protein complex ( Figure 6D ). Although our genetic interaction experiments provide strong support that TOR's action depends on protein translation, we wished to test this issue directly by asking whether the TOR induced increase in QC was sensitive to pharmacological interference with translation. For this we fed control Figure 6 . Postsynaptic TOR or S6K Gain of Function Both Induce Excessive Neurotransmitter Release that Is Sensitive to eIF4E Activity (A) EJCs and mEJCs in controls (G14-Gal4/+), TOR OE larvae (G14-Gal4/+; +/UAS-TOR) and TOR OE larvae lacking one copy of eIF4E (G14-Gal4/+; eIF4E S058911 / UAS-TOR). (B) Quantification for mEJC, EJC, and QC for the genotypes shown in (A) as well as for TOR OE larvae lacking one copy of brp (G14-Gal4/brp 69 ; UAS-Tor/+) or S6k (G14-Gal4/+; UAS-Tor/S6k l-1 ). n = 21, 22, 14, 12, 9.
(C) QC measured by failure analysis in wild-type and TOR OE (MHC-Gal4/UAS-TOR) larvae. n = 8 and 11. (D) Quantification for mEJC, EJC, and QC for controls (G14-Gal4/+), larvae OE activated S6K (G14-Gal4/+; +/UAS-S6K STDE ), and larvae OE activated S6K but lacking one copy of eIF4E (+/G14-Gal4; UAS-S6K STDE /eIF4E S059811 ). Like TOR, postsynaptic OE of activated S6K increases EJCs and QC without affecting mEJCs and can be dominantly suppressed by removal of one copy of eIF4E. n = 21, 22, 20. (E) QC measured by failure analysis in control (G14-Gal4/+) and activated S6K OE (G14-Gal4/+; +/UAS-S6K STDE ) larvae. n = 10 and 14. Two-tailed student's t test was applied for the comparison. Terminal boutons from muscle 6/7 NMJs of controls (MHC-Gal4/+, F-H) or larvae OE TOR (MHC-Gal4/UAS-TOR, I-K), or S6K (MHC-Gal4/ UAS-S6K STDE , L-N), double-stained with anti-Brp (green) and anti-HRP. Scale bar, 5 mm.
(O) Quantification of the NMJ area, total number of active zones, and density of active zones per NMJ area in the indicated genotypes. n = 10 each. All error bars represent SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S5 . larvae and larvae overexpressing TOR postsynaptically either regular food or food containing 500 mg/ml cycloheximide, a potent inhibitor of translation. This concentration of cycloheximide causes complete growth and developmental arrest (Britton and Edgar, 1998) . Overnight treatment (14-16 hr) of control larvae with cycloheximide had no effect on base line electrophysiology at the NMJ ( Figure S5K ). On the other hand, the same treatment profoundly suppressed the increase in quantal content that is normally induced by postsynaptic overexpression of TOR (Figures S5J-S5K ). These results provide further evidence indicating that retrograde enhancement of QC by postsynaptic TOR depends on de novo protein synthesis during larval development.
The important role of S6K downstream of TOR prompted us to further test other candidate translation factors that can be regulated by S6K. One way in which S6K can influence translation initiation is through its phosphorylation of initiation factor 4B (eIF4B) and thereby enhancing the activity of eIF4A (Gingras et al., 2001; Sonenberg and Hinnebusch, 2009 ). To test this possibility, we used an alternative genetic manipulation to induce retrograde compensation at the NMJ: muscle overexpression of a dominant-negative GluRIIA transgene (GluRIIA M/R ). Overexpression of GluRIIA M/R leads to a strong reduction in mEJCs and a subsequent enhancement of QC similarly to the case of loss of GluRIIA (Petersen et al., 1997) (Figures S5L and  S5M ). We first tested whether this induction in QC showed the same sensitivity to genetic manipulation of TOR as we have observed in GluRIIA mutants. Indeed, heterozygosity for Tor significantly suppressed the QC enhancement in larvae overexpressing the GluRIIA M/R transgene ( Figures S5L and S5M ). Next, we tested whether heterozygosity for eIF4A could suppress the increase in QC and found that in this case there was a trend toward suppression but without statistical significance (Figure S5M ). Finally we tested whether overexpression of eIF4B-RNAi would cause any suppression of QC, and found that reducing eIF4B in muscles ( Figure S5N ) caused a significant suppression in EJCs and QC in larvae expressing GluRIIA M/R postsynaptically ( Figures S5L and S5M ). We also tested the effect of loss of one copy of Ef2b (homolog of the mammalian eEF2, an elongation factor that has been shown to be influenced by S6K activity indirectly), but found no suppression of QC or EJCs (data not shown). These results suggest that S6K, at least partially, exerts its action through eIF4B; however, we cannot rule out a direct interaction between S6K and eIF4E or an effect on other ribosomal proteins by S6K.
TOR Acts Genetically Downstream of GluRIIA to Regulate Retrograde Signaling
Our findings thus far suggest strongly that the retrograde increase in neurotransmitter release in GluRIIA mutants and that induced by TOR overexpression in muscles most likely rely on a common mechanism that ultimately depends on S6K and eIF4E function. Based on this rationale, overexpressing TOR in GluRIIA mutant larvae should not produce any significant additional increase in QC. Indeed our elecrophysiological analysis showed that the increase in neurotransmitter release was statistically indistinguishable in GluRIIA mutants, TOR overexpression and the combination of the two ( Figures 7A and 7B ). In addition while removal of one copy of TOR greatly suppressed the increase in neurotransmitter release in GluRIIA mutants, loss of one copy of GluRIIA had no effect on the TOR-induced increase in QC ( Figures 7A and 7B ). These results suggest that the mechanism underlying the homeostatic compensation in neurotransmitter release in GluRIIA mutants and that in response to overexpression of TOR share a common pathway and that normally TOR functions downstream of GluRIIA.
Complexity of the Secondary Structure of 5 0 UTRs Confers Sensitivity to Enhanced TOR Activity In Vivo Excessive secondary structure in the 5 0 UTR of mRNAs can negatively influence translation; in particular the activity of the cap-binding complex is important for unwinding of the 5 0 UTR prior to the binding of the ribosome and initiation of translation (Ma and Blenis, 2009; Sonenberg, 1994) . Based on our results, we reasoned that TOR activity in postsynaptic muscles could influence translation of specific genes based on the complexity of their 5 0 UTR. To test this hypothesis we conducted a comprehensive sorting of the 5 0 UTRs of all predicted Drosophila melanogaster mRNAs (http://flybase.org; R5.29 genome release) based on (B) Quantification for mEJC, EJC, and QC in the indicated genotypes. n = 12, 16, 11, 21. Removal of one copy of GluRIIA has no effect on TOR OE, while TOR OE has no additive effect in GluRIIA mutants. All error bars represent SEM. NS, no significance; **p < 0.01, ***p < 0.001.
their folding free energy (DG) as a measure of their secondary structure stability. DG values were calculated for the 5 0 UTRs of 19,924 transcripts at a physiologically relevant temperature of 25 C and ranked from lowest DG to highest. Values ranged from 2.85 kcal/mol (least stable, least complex) to À2,340 kcal/mol (most stable, most complex). We then chose three transcripts as representatives of the top 10 th percentile (Furin 1, DG = À221 kcal/mol), top 30 th percentile (Rac1, DG = À89.01 kcal/mol) and bottom 50 th percentile (Glass bottom boat [gbb] , DG = À44.47 kcal/mol) and used their 5 0 UTRs in a luciferase reporter assay (see Experimental Procedures). We found that inclusion of 5 0 UTR of Furin 1 severely reduced the translation of luciferase compared to control, while 5 0 UTRs of gbb and Rac1 had only a moderate effect on luciferase translation ( Figures 8A and 8B ), supporting the idea that 5 0 UTR complexity is an important factor in determining the rate of translation.
Next, in order to test whether the same is true in a living organism, we set out to conduct an in vivo reporter assay using Furin1 5 0 UTR. We generated a transgene driving the expression of EGFP bearing the 5 0 UTR of Furin1. Then we overexpressed this transgene in muscle, either alone, or together with TOR. We measured the level of EGFP optically and found a strong enhancement of the fluorescent signal in muscles ( Figures 8C and 8D) . In larvae overexpressing TOR, we found a strong increase in GFP expression associated with Fur1-5 0 UTR-EGFP compared to Actin levels (Actin with a DG of À33 acts as a good control) ( Figures 8E and 8F) ; interestingly, we found no difference in the level of GFP expression in heterozygous Tor +/À mutants compared to wild-type ( Figures 8G and   8H ). These results suggest that the complexity of 5 0 UTR of mRNAs can determine their sensitivity to enhanced TOR activity and therefore contribute to the specificity of TOR's action in inducing retrograde signaling at the synapse.
DISCUSSION
Cap-Dependent Translation, under the Influence of TOR, Is Essential for Retrograde Signaling across the Synapse A growing consensus by neurobiologists suggests that a balance exists between forces that promote and those that hinder synaptic growth and function, ensuring proper synaptic connectivity and functional stability in the nervous system (Davis, 2006; Turrigiano and Nelson, 2004) . We now know that this balance, or homeostasis, requires both anterograde and retrograde signaling at the synapse (Davis, 2006; Turrigiano, 2008; Turrigiano and Nelson, 2004) . A robust retrograde signaling mechanism at the Drosophila NMJ carries out the task of adjusting synaptic strength in response to a reduction in postsynaptic receptor function in GluRIIA mutants. Our genetic analysis suggests that postsynaptic activity of TOR plays a key role in the ability of this retrograde signaling to carry out its function. Our findings are consistent with a model in which TOR, through activation of S6K and inhibition of 4E-BP, ensures the efficiency of cap-dependent translation in muscles and allows for the retrograde compensation to take place ( Figure 8I ).
Interestingly, a moderate to strong reduction in TOR activity in the Tor E161K /Tor DP mutant combination does not influence normal synaptic growth and has only a mild effect on baseline synaptic transmission. However, our findings indicate that once synaptic activity is compromised, i.e., in GluRIIA mutants, TOR becomes critical for the retrograde induction of homeostatic signaling. Furthermore, our findings suggest that TOR activity is required throughout larval development, as its inhibition by rapamycin for 12 hr during late stages of larval development is sufficient to block the retrograde signal. In addition, we found that TOR can induce a retrograde increase in neurotransmitter release in wild-type animals, indicating that TOR can also act as an instructive force to regulate synaptic strength. These results together lead one to envision that under metabolic stress, during dietary restriction or as a result of aging perhaps, TOR could function as a modulator of neuronal function. As such, the identification of TOR as a key player in establishing retrograde signaling across synapses offers new insights into how defects in this aspect of translational regulation may underlie the destabilization of synaptic activity in neural circuits leading to abnormal neural function and behavior associated with diseases such as tuberous sclerosis complex (TSC), autism, mental retardation, and schizophrenia, where regulation of TOR activity may be altered (Buckmaster et al., 2009; Ehninger et al., 2008; Emamian et al., 2004; Hoeffer and Klann, 2010; Kelleher and Bear, 2008; Sharma et al., 2010; Swiech et al., 2008) . In fact, in animal models for TSC, hyperactivity in circuits and the susceptibility to epileptic activity can be diminished in response to rapamycin treatment (Meikle et al., 2008) . Based on our results, it is conceivable that in TSC animals, when TOR is upregulated, synaptic activity in circuits is enhanced due to the retrograde action of TOR on neurotransmitter release, in a manner independent of growth related phenotype associated with TOR gain of function. Therefore, our results reveal a role for TOR in the retrograde regulation of neurotransmitter release in neurons, an avenue to explore aimed at potential therapeutic approaches.
TOR, a Modulator of Synaptic Activity
Based on our genetic interaction experiments and biochemical assessment, we conclude that TOR normally acts downstream of synaptic activity. We observed that postsynaptic phosphorylation of S6K, a bona fide TOR target, is increased in GluRIIA mutants, suggesting that TOR signaling may be upregulated in these mutants. Consistently, our genetic experiments show that removal of one gene copy of either Tor or S6k is sufficient to block the homeostatic response in GluRIIA mutants. Furthermore, when TOR is overexpressed in GluRIIA mutants no additional increase in quantal content is observed. This lack of an additive effect suggests that a common molecular pathway may be utilized by GluRIIA mutants and larvae overexpressing TOR ( Figure 8I ). This is further supported by our observations that the enhancement in neurotransmission in response to TOR (or S6K) overexpression and that triggered in GluRIIA loss of function are both highly dependent on wild-type availability of eIF4E. These results together support the idea that TOR functions downstream of synaptic activity at the NMJ. Further experiments are needed to understand how changes in synaptic activity may regulate the activity of TOR. Our findings are consistent with a growing body of evidence that implicates the involvement of TOR/S6K in the regulation of synaptic plasticity in mammals (Antion et al., 2008; Hoeffer and Klann, 2010; Jaworski and Sheng, 2006) . Our results indicate that TOR/S6K may be exerting their function through a retrograde mechanism to enhance neurotransmission. As such, our findings reveal a novel mode of action for TOR, through which it can modulate circuit activity in higher organisms. Further experiments are required to verify if this mode of action is conserved in higher organisms.
Local Protein Synthesis and Retrograde Signaling
One potential way in which general translational mechanisms can lead to specific changes in synaptic function is through localized translation. In both vertebrates and invertebrates, local postsynaptic translation is required for normal synaptic plasticity and is itself modulated by synaptic function (Liu-Yesucevitz et al., 2011; Sigrist et al., 2000; Sutton and Schuman, 2006; Wang et al., 2009) . This is perhaps best demonstrated in cultured hippocampal neurons, where local protein synthesis at postsynaptic sites is regulated by postsynaptic activity. It appears that this modulation is, at least in part, mediated by the action of synaptic activity on the function of elongation factor, eEF2. Interestingly, blocking NMDA mediated miniatures leads to phosphorylation and inhibition of eEF2 (Sutton et al., 2007) . Our findings are consistent with a role for miniature synaptic activity in the regulation of postsynaptic translation: in GluRIIA mutants, a reduction in miniature amplitude (and perhaps in postsynaptic calcium influx) leads to an upregulation of TOR activity as evident in the increase in S6K phosphorylation. However, at this point we cannot conclusively show that the effect of postsynaptic TOR is localized. Further experiments are needed to verify whether these changes occur at specific postsynaptic loci at the NMJ.
Potential Gene Targets Involved in the Regulation of Retrograde Signaling
Our results indicate that different manipulations of translational machinery can have vastly different consequences for retrograde signaling at NMJ synapses. In particular, we show that the homeostatic response at the NMJ in GluRIIA mutants is critically dependent on the efficiency of the cap-binding protein complex but is less sensitive to the availability of the ternary complex. Similarly, while very strong inhibition of translation at the level of elongation using cycloheximide can block the retrograde compensation, revealing that retrograde compensation relies on de novo protein synthesis, moderate genetic interference with translation elongation does not interfere with retrograde signaling. These results together highlight the critical role of the cap-dependent protein complex in the retrograde regulation of synaptic strength.
The major task of the cap-binding complex is binding to the 5 0 UTR of the mRNA and unwinding it, so that the ribosome can interact with the mRNA and initiate translation (Ma and Blenis, 2009 ). Our results suggest that this stage of translation is the most critical for the induction of retrograde compensation. As our results suggest, once the 5 0 UTR is unwound, changes in the availability of the ternary complex and translation elongation are less critical for the induction of retrograde signaling. On the other hand, TOR would have a two-fold function in this scenario: one through its inhibitory action on 4E-BP, promoting eIF4Es ability to bind the 5 0 cap structure, and another through its activation of S6K, which would ultimately increase the helicase ability of eIF4A to unwind mRNA 5 0 UTR secondary structure. This notion was supported by the results of our in vivo reporter assay showing a significant increase in translation of a reporter that bore a complex 5 0 UTR in response to TOR overexpression. Based on our findings, we speculate that perhaps genes with highly structured 5 0 UTRs are among the mRNAs triggered when postsynaptic activity is reduced in GluRIIA mutants or when TOR is overexpresed in muscles. The next challenge is to identify and characterize these genes, a discovery that will likely lead to a better understanding of how homeostatic mechanisms are regulated at the synapse.
EXPERIMENTAL PROCEDURES

Fly Stocks
Flies were cultured on standard medium at 25 C following standard protocol.
For description of stocks see Supplemental Experimental Procedures.
Immunostaining
Wandering third-instar larvae were dissected following standard protocol. See Supplemental Experimental Procedures for more detail.
Electrophysiology
The spontaneous (mEJC) and evoked (EJC) membrane currents were recorded from muscle 6 in abdominal segment A3 with standard two-electrode voltage-clamp technique. For details and the conditions for the Failure Analysis, see Supplemental Experimental Procedures.
Western Blot Analysis
Standard protocols were used from protein extracts of dissected muscles. See Supplemental Experimental Procedures for more detail.
Imaging and Data Analysis
For quantifications, boutons at the NMJ from muscle 6/7 segment A3 were counted following immunofluorescent staining. See Supplemental Experimental Procedures for details.
Luciferase Assay
Standard protocols were used. Probes were constructed using PSICHECK-2 vector (Promega). For details see Supplemental Experimental Procedures.
Statistical Analysis
Data are presented as mean ± SEM (n = number of NMJs unless otherwise indicated). 
